BackBiotech Acquisition Co - Warrants (30/11/2027) Overview

Biotech Acquisition Co - Warrants (30/11/2027) Common Stock

Biotech Acquisition Co - Warrants (30/11/2027)'s common stock is $230M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$231.29M
↑ 0.56% YoYΔ $1.28M vs prior year quarter

Peer trimmed avg / median

Loading

Biotech Acquisition Co - Warrants (30/11/2027) Common Stock History

Loading

Biotech Acquisition Co - Warrants (30/11/2027) vs. peers: Common Stock Comparison

Loading

Biotech Acquisition Co - Warrants (30/11/2027) Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) FAQ

As of the most recent data (September 2022), BIOTW shows a common stock of $230M. That compares with $230M in the prior-year period — up 0.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOTW's common stock is now $230M (was $230M) — a 0.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition Co - Warrants (30/11/2027) is outperforming or lagging.

Tracking BIOTW's common stock over time shows whether Biotech Acquisition Co - Warrants (30/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $230M That compares with $230M in the prior-year period — up 0.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Biotech Acquisition Co - Warrants (30/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $230M) with ownership activity and broader fundamentals.